Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Irène

Gallais Sérézal

,

PhD

Dermatologist
Besancon University Hospital
Besançon
,
France
Councilor Since: September 8, 2023
IPC Councilor
Dr. Irene Gallais Sérézal works at the Besançon University Hospital in Besançon, France. She obtained her PhD at the Karolinska Institutet in Sweden and graduated as a dermatologist in Paris, France. Dr. Gallais Sérézal has experience in psoriasis care in France and Sweden, where she worked at the Karolinska University Hospital and at the Swedish patient–driven psoriasis clinics. Her PhD work in The Eidsmo Laboratory has helped better understand the implication of disease memory, especially skin-resident T cells, in the relapses of psoriasis. She now drives her independent line of work in France, deciphering the factors underlying the dwelling of these T cells in the skin, hoping to identify disease-relevant factors that could minimize relapses in psoriasis patients. Dr. Gallais Sérézal is a member of the French Society of Dermatology, active in its psoriasis research group, and a member of the European Society for Dermatological Research (ESDR).
Last Updated:
10/24/2023

Areas of Interest

My main interest in the clinic and translational research is optimizing systemic treatments in psoriasis: when to start, when to stop, and how to individually optimize the treatment regimen.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026